Which drug is approved for the treatment of obesity?
The FDA has approved five of these drugs—orlistat (Xenical, Alli), phentermine-topiramate (Qsymia), naltrexone-bupropion (Contrave), liraglutide (Saxenda), and semaglutide (Wegovy)—for long-term use.
What is the most effective medical treatment for obesity?
The most commonly used medications approved by the U.S. Food and Drug Administration (FDA) for the treatment of obesity include: Bupropion-naltrexone (Contrave) Liraglutide (Saxenda) Orlistat (Alli, Xenical)
Are antibiotic doses based on weight?
Whereas children’s antibiotic dosing is generally calculated according to body mass, for adults, no such system is in place, and for those drugs that do have body mass specific guidelines for dosing, adherence is “inadequate,” according to the authors.
Does body weight affect drug absorption?
As clearance determines a drug’s maintenance dose, clinicians should consider how lean body weight, rather than total body weight, impacts dosing. When lean body weight increases there will be a corresponding increase in drug clearance and an increased dose may be required.
Which anti obesity medication can reduce lipid absorption in the gut?
Orlistat (Xenical) is a lipase inhibitor that prevents the absorption of dietary fat, and it has been approved as an anti‐obesity drug.
Do you need to be weighed for antibiotics?
In antibiotics a correct, recent patient weight is required for accurate dosing and to keep drugs within the narrow therapeutic index, to ensure efficacy of prescribing and reduce toxicity.
How does obesity affect drug elimination?
In general, studies have shown that clearance of renally eliminated drugs is higher in obese patients. This increase in CL is likely due to increased glomerular filtration and tubular secretion.
What happens when an obese person is given a lipophilic drug?
Oral drug absorption is not altered by obesity. Lipophilic drugs may take longer to reach steady state than hydrophilic ones as there is increased fat mass, taking these drugs longer to saturate the fat compartment. Subcutaneous and intramuscular routes of administration may have an unpredictable effect in the obese.